Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1960 1
1963 2
1965 1
1967 1
1969 1
1970 1
1975 1
1976 1
1980 1
1981 1
1982 2
1984 1
1985 2
1986 3
1987 7
1988 7
1989 6
1990 5
1991 9
1992 5
1993 14
1994 18
1995 29
1996 18
1997 13
1998 13
1999 25
2000 31
2001 41
2002 50
2003 60
2004 73
2005 90
2006 104
2007 94
2008 123
2009 133
2010 132
2011 160
2012 178
2013 191
2014 213
2015 236
2016 229
2017 264
2018 306
2019 365
2020 425
2021 576
2022 594
2023 579
2024 220

Text availability

Article attribute

Article type

Publication date

Search Results

5,045 results

Results by year

Filters applied: . Clear all
Page 1
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, Kitazono S, Thiagarajan M, Goldman JW, Sabari JK, Sanborn RE, Mansfield AS, Hung JY, Boyer M, Popat S, Mourão Dias J, Felip E, Majem M, Gumus M, Kim SW, Ono A, Xie J, Bhattacharya A, Agrawal T, Shreeve SM, Knoblauch RE, Park K, Girard N; PAPILLON Investigators. Zhou C, et al. Among authors: tang kj. N Engl J Med. 2023 Nov 30;389(22):2039-2051. doi: 10.1056/NEJMoa2306441. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870976 Clinical Trial.
Antimicrobial Resistance (AMR).
Tang KWK, Millar BC, Moore JE. Tang KWK, et al. Br J Biomed Sci. 2023 Jun 28;80:11387. doi: 10.3389/bjbs.2023.11387. eCollection 2023. Br J Biomed Sci. 2023. PMID: 37448857 Free PMC article. Review.
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP; ORBITA investigators. Al-Lamee R, et al. Among authors: tang k. Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9. Epub 2017 Nov 2. Lancet. 2018. PMID: 29103656 Free article. Clinical Trial.
CTLA-4 tail fusion enhances CAR-T antitumor immunity.
Zhou X, Cao H, Fang SY, Chow RD, Tang K, Majety M, Bai M, Dong MB, Renauer PA, Shang X, Suzuki K, Levchenko A, Chen S. Zhou X, et al. Among authors: tang k. Nat Immunol. 2023 Sep;24(9):1499-1510. doi: 10.1038/s41590-023-01571-5. Epub 2023 Jul 27. Nat Immunol. 2023. PMID: 37500885
Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG.
Chen J, Zhou Y, Liu Z, Lu Y, Jiang Y, Cao K, Zhou N, Wang D, Zhang C, Zhou N, Shi K, Zhang L, Zhou L, Wang Z, Zhang H, Tang K, Ma J, Lv J, Huang B. Chen J, et al. Among authors: tang k. Science. 2024 Feb 16;383(6684):eadi3332. doi: 10.1126/science.adi3332. Epub 2024 Feb 16. Science. 2024. PMID: 38359126
CTLA-4 tail fusion enhances CAR-T anti-tumor immunity.
Zhou X, Cao H, Fang SY, Chow RD, Tang K, Majety M, Bai M, Dong MB, Renauer PA, Shang X, Suzuki K, Levchenko A, Chen S. Zhou X, et al. Among authors: tang k. bioRxiv [Preprint]. 2023 Mar 15:2023.03.14.532655. doi: 10.1101/2023.03.14.532655. bioRxiv. 2023. PMID: 36993364 Free PMC article. Updated. Preprint.
Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.
Cornwell JA, Crncec A, Afifi MM, Tang K, Amin R, Cappell SD. Cornwell JA, et al. Among authors: tang k. Nature. 2023 Jul;619(7969):363-370. doi: 10.1038/s41586-023-06274-3. Epub 2023 Jul 5. Nature. 2023. PMID: 37407814 Free PMC article.
5,045 results